Six challenges facing emerging biotechs and how to solve them
Handing over your molecule is a big step for emerging biotechs. The process of developing new drugs is complex and…
Handing over your molecule is a big step for emerging biotechs. The process of developing new drugs is complex and…
Early stage biotech companies (biotechs) rely heavily on external funding to advance their research and development (R&D) programs. Robust fundraising…
According to a comprehensive overview, recruitment challenges are among the most persistent barriers to timely trial completion, often leading to…
On January 6, 2025, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) issued its…
As of April 2025, GlobalData’s Drugs database shows 8,684 investigative drugs under active development by emerging pharmaceutical companies, which are…
Global immunization programs have successfully eradicated or controlled many infectious diseases throughout history. However, challenges like antimicrobial resistance, climate change,…
May 2025 - London & Boston - Perceptive eClinical unveils ClinPhone Pro, a next-generation RTSM platform. Built on over 30…
It’s 2025 and it appears that turbulence is now the new normal in clinical trials. From public health emergencies to…
Melissa Peirsel is the Manager of IRT Services at Sharp and brings over 13 years of experience in clinical trial…
When preparing for an upcoming drug development program, leveraging existing knowledge and strategies to streamline the process from concept to…